title: Bacteroides fragilis group infections in HIV-infected patients. The Bacteroides Study Group.
authors.affiliation: Département des Maladies Infectieuses et Tropicales, CHI-Villeneuve Saint Georges, France.
authors.forename: O
authors.initials: O
authors.lastname: Patey
authors.forename: J
authors.initials: J
authors.lastname: Breuil
authors.forename: J E
authors.initials: JE
authors.lastname: Malkin
authors.forename: T
authors.initials: T
authors.lastname: Fosse
authors.forename: T
authors.initials: T
authors.lastname: Prazuck
authors.forename: C
authors.initials: C
authors.lastname: Chaplain
authors.forename: E
authors.initials: E
authors.lastname: Varon
authors.forename: L
authors.initials: L
authors.lastname: Guet
authors.forename: A
authors.initials: A
authors.lastname: Dublanchet
authors.forename: C
authors.initials: C
authors.lastname: Lafaix
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000453:epidemiology*; D000328:Adult; D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis; D016470:Bacteremia / Q000382:microbiology; D001442:Bacteroides Infections / Q000453:epidemiology* / Q000517:prevention & control; D001441:Bacteroides fragilis / Q000187:drug effects; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies
chemical_list: D019380:Anti-HIV Agents